Erlotinib hydrochloride 183319-69-9 C22H24ClN3O4
high quality
Erlotinib hydrochloride Basic information |
Product Name: | Erlotinib hydrochloride |
Synonyms: | ERLOTINIB HCL;ERLOTINIB HCL SALT;ERLOTINIB HCL SALT :TARCEVA;Erlotinib, Hydrochloride Salt;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, Hydrochloride Salt, OSI 774, Tarceva;N-(3-Ethynylphenyl)-6,7-bis-(2-methoxyethoxy)-quinazolin-4-amine;[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4yl]-(3-ethynyl-phenyl)-amine;Tarceva HydrochlorideSee E625000 |
CAS: | 183319-69-9 |
MF: | C22H24ClN3O4 |
MW: | 429.9 |
EINECS: | |
Product Categories: | API;Molecular Targeted Antineoplastic;Heterocyclic Compounds;anti-neoplastic;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Tarceva;Antineoplastic;Anti-cancer&immunity |
Mol File: | 183319-69-9.mol |
Erlotinib hydrochloride Chemical Properties |
mp | 223-225°C |
storage temp. | -20°C Freezer |
CAS DataBase Reference | 183319-69-9(CAS DataBase Reference) |
Safety Information |
Erlotinib hydrochloride Usage And Synthesis |
Chemical Properties | Off-White Solid |
Usage | Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor. Antineoplastic |
Usage | Erlotinib HCl is an HER1/EGFR inhibitor with IC50 of 2 nM. |
Usage | Erlotinib HCl (OSI-744) is an EGFR inhibitor with IC50 of 2 nM, >1000-fold more sensitive for EGFR than human c-Src or v-Abl. Phase 3. |
Erlotinib hydrochloride Preparation Products And Raw materials |
CAS NO:3164-13-4
CAS NO:64519-44-4
CAS NO:1194-98-5
CAS NO:92-67-1
CAS NO:106556-36-9
CAS NO:105-84-0
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View